Requires death certificates to include drug responsible for drug overdose death under certain circumstances.
Summary
Assembly Bill 1767 would amend New Jersey’s death certificate law to require that, when a death is caused by a drug overdose and the information is available, the specific drug responsible for the overdose be listed on the death certificate or entered into the New Jersey Electronic Death Registration System. The bill leaves the existing required death-certificate fields in place, but adds this overdose-specific reporting requirement to improve the detail captured in official mortality records.
The bill also retains and restates existing provisions governing how a decedent’s sex is recorded on a death certificate, including rules intended to reflect the decedent’s gender identity when supported by documentation or information from the person with authority over funeral and disposition arrangements. It preserves the ability of an executor to seek a Superior Court determination if there is a dispute, and it continues liability protections for funeral directors who rely on the information provided in good faith.
Impact
The bill would amend R.S.26:6-7, New Jersey’s death-certificate statute, by adding a requirement that the drug causing a fatal overdose be included on the death certificate or in NJ-EDRS when available. In practical terms, this would affect medical certifiers, funeral directors, and the state’s vital records system by increasing the specificity of overdose death reporting and potentially improving public health surveillance, overdose trend analysis, and data used for prevention and policy responses. The bill does not create a new criminal or civil penalty, but it does alter the information that must be captured in official death records.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate or formal support/opposition in the available materials. Based on the bill text and sponsor statement, the measure appears to be framed as a public-health and record-accuracy bill, with an emphasis on improving overdose data. The inclusion of the gender-identity provisions suggests the bill also continues an existing policy approach in death-record administration rather than reopening that issue.
Contention
The main potential point of contention is the accuracy and availability of overdose-drug information, since the bill only requires listing the drug if that information is available. Another possible area of concern is the bill’s retention of gender-identity recording rules, including the hierarchy of documentation and the court-petition process when there is disagreement between an executor and those with control over funeral arrangements. Those provisions could draw attention from advocates concerned about transgender record accuracy, family authority, or administrative burden, although no specific objections are documented in the provided materials.